Organization and Nature of Business (Details)	0 Months Ended		1 Months Ended							1 Months Ended
	Jan. 16, 2008 Viscorp Inc. [Member] USD ($)	Sep. 30, 2007 Grandway Groups Holdings Ltd. [Member]	Nov. 30, 2012 Chengdu Tianyin Pharmaceutical Co., Ltd. [Member] USD ($)	Aug. 29, 2012 Chengdu Tianyin Pharmaceutical Co., Ltd. [Member] USD ($)	Aug. 29, 2012 Chengdu Tianyin Pharmaceutical Co., Ltd. [Member] CNY	Jul. 30, 2009 Chengdu Tianyin Pharmaceutical Co., Ltd. [Member] USD ($)	Jul. 30, 2009 Chengdu Tianyin Pharmaceutical Co., Ltd. [Member] CNY	Jun. 30, 2013 Chengdu Tianyin Pharmaceutical Co., Ltd. [Member] USD ($)	Oct. 30, 2007 Chengdu Tianyin Pharmaceutical Co., Ltd. [Member]	Aug. 31, 2012 Chengdu Tianyin Medicine Trading Co., Ltd. [Member] shareholder	Mar. 31, 2013 Sichuan Jiangchuan Pharmaceutical Co., Ltd. [Member] USD ($)	Aug. 21, 2009 Sichuan Jiangchuan Pharmaceutical Co., Ltd. [Member] USD ($)	Aug. 21, 2009 Sichuan Jiangchuan Pharmaceutical Co., Ltd. [Member] CNY
Organization and Nature of Business (Textual)
Common stock issued in acquisition of Raygere Limited	12,790,800
Ratio common stock issued in exchanged of equity interest in Raygere	One-to-one ratio.
Percentage of equity interest acquired in subsidiary	100.00%	100.00%
Amount of assets Viscorp was delivered at time of closing	$ 0
Amount of liabilities Viscorp was delivered at time of closing	0
Percentage of interest acquired in an indirect wholly owned subsidiary									100.00%
Cost incurred to establish a wholly-owned trading subsidiary for sales and distribution of medicine						700,000	5,000,000
Registered capital of subsidiary											3,200,000	3,200,000	20,000,000
Percentage of registered capital accounted by subsidiary												87.00%	87.00%
Number of existing shareholders entered into share transfer agreement with the company										2
Ownership percentage owned			100.00%	100.00%	100.00%
Total purchase consideration of acquired entity			210,600	210,600	1,300,000
Purchase price allocated to goodwill								$ 210,600